Astrid M Botty Van den Bruele

6PUBLICATIONS
10CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Models of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 26, 2025
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.

Ton Wang, Drew Neish, Samantha M Thomas

|Feb 27, 2025
High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.

Astrid Botty van den Bruele, Yi Ren, Samantha M Thomas

|Jan 13, 2025
Commentary and Updates on the Management of Male Breast Cancer.

Astrid Botty van den Bruele, Austin Williams, Anna Weiss

|Jul 05, 2024
Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.

Astrid Botty van den Bruele, Anna Weiss

|Feb 23, 2024
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.

Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta

|Jul 20, 2020
Breast lidocaine priming for improved mastectomy survival.

Astrid M Botty Van den Bruele, Marie Crandall, David Chesire

Pageof 1

Frequent Collaborators

2 joint publications

Jennifer K Plichta

2 joint publications

Laura H Rosenberger

2 joint publications

Maggie L DiNome

1 joint publications

Ton Wang